PBH
Prestige Consumer HealthcareFNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade F from latest DB weights. Momentum 6.5 / Value 69.5
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.4.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
6
Value
70
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $77.40
Why
Momentum6 · Δ7d -0.7
Value70 · Δ7d +0.4
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
6
52% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-6.2
Value
70
48% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
+0.9
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 6.5 / Value 69.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$2.17B
Beta
0.43
Shares Out
48.08M
P/E (TTM)
15.5
P/S (TTM)
2.71
P/FCF (TTM)
11.76
Rev YoY
-3.4%
EPS YoY
-21.2%
Gross Margin
+56.1%
Op Margin
+29.9%
Net Debt
$917.59M
Current Ratio
3.70
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology